1. Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada;
2. The University of Toronto, Toronto, ON, Canada;
3. Department of Hematology, John Theurer Cancer Center, Hackensack, NJ;
4. Siteman Cancer Center, Washington University in Saint Louis, Saint Louis, MO;
5. Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH;
6. Gabrail Cancer Institute, Canton, OH;
7. Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;
8. Department of Oncology, Rigshospitalet, Copenhagen, Denmark;
9. Blood Cancer Research Program, Sarah Cannon Research Institute, Nashville, TN;
10. Division of Hematology & Oncology, Vanderbilt-Ingram Cancer Center/Vanderbilt University Medical Center, Nashville, TN;
11. Tom Baker Cancer Centre Division of Hematology, University of Calgary, Calgary, AB, Canada; and
12. Karyopharm Therapeutics Inc, Newton, MA